Selected research
Market Analysis & Forecast
Global Calcitonin Injection Market Analysis and Forecast 2026-2032
Market perspective
The global Calcitonin Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Calcitonin Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Calcitonin Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Calcitonin Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Calcitonin Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Calcitonin Injection include Yingu, Shanghai No.1 Bio, Qingdao Guoda, Novartis, Guilin Pharma, Chengdu List Pharma, Lisapharma, Hybio Pharmaceutical and Guoda Bio, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Calcitonin Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Calcitonin Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Calcitonin Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Calcitonin Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Calcitonin Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Calcitonin Injection sales, projected growth trends, production technology, application and end-user industry.
Calcitonin Injection Segment by Company
Yingu
Shanghai No.1 Bio
Qingdao Guoda
Novartis
Guilin Pharma
Chengdu List Pharma
Lisapharma
Hybio Pharmaceutical
Guoda Bio
Future Health Pharma
DAPHAE
CSPC
Asahi Kasei Pharma
Calcitonin Injection Segment by Type
Elcatonin Injection
Salmon Calcitonin Injection
Calcitonin Injection Segment by Application
Hospital
Clinic
Calcitonin Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Calcitonin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Calcitonin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Calcitonin Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Calcitonin Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Calcitonin Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Calcitonin Injection sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Elcatonin Injection
- Salmon Calcitonin Injection
Applications
- Hospital
- Clinic
Companies covered
- Yingu
- Shanghai No.1 Bio
- Qingdao Guoda
- Novartis
- Guilin Pharma
- Chengdu List Pharma
- Lisapharma
- Hybio Pharmaceutical
- Guoda Bio
- Future Health Pharma
- DAPHAE
- CSPC
- Asahi Kasei Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Calcitonin Injection Market by Type
- 1.2.1 Global Calcitonin Injection Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Elcatonin Injection
- 1.2.3 Salmon Calcitonin Injection
- 1.3 Calcitonin Injection Market by Application
- 1.3.1 Global Calcitonin Injection Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Calcitonin Injection Market Dynamics
- 2.1 Calcitonin Injection Industry Trends
- 2.2 Calcitonin Injection Industry Drivers
- 2.3 Calcitonin Injection Industry Opportunities and Challenges
- 2.4 Calcitonin Injection Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Calcitonin Injection Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Calcitonin Injection Revenue by Region
- 3.2.1 Global Calcitonin Injection Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Calcitonin Injection Revenue by Region (2021-2026)
- 3.2.3 Global Calcitonin Injection Revenue by Region (2027-2032)
- 3.2.4 Global Calcitonin Injection Revenue Market Share by Region (2021-2032)
- 3.3 Global Calcitonin Injection Sales Estimates and Forecasts 2021-2032
- 3.4 Global Calcitonin Injection Sales by Region
- 3.4.1 Global Calcitonin Injection Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Calcitonin Injection Sales by Region (2021-2026)
- 3.4.3 Global Calcitonin Injection Sales by Region (2027-2032)
- 3.4.4 Global Calcitonin Injection Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Calcitonin Injection Revenue by Manufacturers
- 4.1.1 Global Calcitonin Injection Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Calcitonin Injection Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Calcitonin Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Calcitonin Injection Sales by Manufacturers
- 4.2.1 Global Calcitonin Injection Sales by Manufacturers (2021-2026)
- 4.2.2 Global Calcitonin Injection Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Calcitonin Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Calcitonin Injection Sales Price by Manufacturers (2021-2026)
- 4.4 Global Calcitonin Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Calcitonin Injection Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Calcitonin Injection Manufacturers, Product Type & Application
- 4.7 Global Calcitonin Injection Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Calcitonin Injection Market CR5 and HHI
- 4.8.2 2025 Calcitonin Injection Tier 1, Tier 2, and Tier 3
5 Calcitonin Injection Market by Type
- 5.1 Global Calcitonin Injection Revenue by Type
- 5.1.1 Global Calcitonin Injection Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Calcitonin Injection Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Calcitonin Injection Revenue Market Share by Type (2021-2032)
- 5.2 Global Calcitonin Injection Sales by Type
- 5.2.1 Global Calcitonin Injection Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Calcitonin Injection Sales by Type (2021-2032) & (k units)
- 5.2.3 Global Calcitonin Injection Sales Market Share by Type (2021-2032)
- 5.3 Global Calcitonin Injection Price by Type
6 Calcitonin Injection Market by Application
- 6.1 Global Calcitonin Injection Revenue by Application
- 6.1.1 Global Calcitonin Injection Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Calcitonin Injection Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Calcitonin Injection Revenue Market Share by Application (2021-2032)
- 6.2 Global Calcitonin Injection Sales by Application
- 6.2.1 Global Calcitonin Injection Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Calcitonin Injection Sales by Application (2021-2032) & (k units)
- 6.2.3 Global Calcitonin Injection Sales Market Share by Application (2021-2032)
- 6.3 Global Calcitonin Injection Price by Application
7 Company Profiles
- 7.1 Yingu
- 7.1.1 Yingu Company Information
- 7.1.2 Yingu Business Overview
- 7.1.3 Yingu Calcitonin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Yingu Calcitonin Injection Product Portfolio
- 7.1.5 Yingu Recent Developments
- 7.2 Shanghai No.1 Bio
- 7.2.1 Shanghai No.1 Bio Company Information
- 7.2.2 Shanghai No.1 Bio Business Overview
- 7.2.3 Shanghai No.1 Bio Calcitonin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Shanghai No.1 Bio Calcitonin Injection Product Portfolio
- 7.2.5 Shanghai No.1 Bio Recent Developments
- 7.3 Qingdao Guoda
- 7.3.1 Qingdao Guoda Company Information
- 7.3.2 Qingdao Guoda Business Overview
- 7.3.3 Qingdao Guoda Calcitonin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Qingdao Guoda Calcitonin Injection Product Portfolio
- 7.3.5 Qingdao Guoda Recent Developments
- 7.4 Novartis
- 7.4.1 Novartis Company Information
- 7.4.2 Novartis Business Overview
- 7.4.3 Novartis Calcitonin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Novartis Calcitonin Injection Product Portfolio
- 7.4.5 Novartis Recent Developments
- 7.5 Guilin Pharma
- 7.5.1 Guilin Pharma Company Information
- 7.5.2 Guilin Pharma Business Overview
- 7.5.3 Guilin Pharma Calcitonin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Guilin Pharma Calcitonin Injection Product Portfolio
- 7.5.5 Guilin Pharma Recent Developments
- 7.6 Chengdu List Pharma
- 7.6.1 Chengdu List Pharma Company Information
- 7.6.2 Chengdu List Pharma Business Overview
- 7.6.3 Chengdu List Pharma Calcitonin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Chengdu List Pharma Calcitonin Injection Product Portfolio
- 7.6.5 Chengdu List Pharma Recent Developments
- 7.7 Lisapharma
- 7.7.1 Lisapharma Company Information
- 7.7.2 Lisapharma Business Overview
- 7.7.3 Lisapharma Calcitonin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Lisapharma Calcitonin Injection Product Portfolio
- 7.7.5 Lisapharma Recent Developments
- 7.8 Hybio Pharmaceutical
- 7.8.1 Hybio Pharmaceutical Company Information
- 7.8.2 Hybio Pharmaceutical Business Overview
- 7.8.3 Hybio Pharmaceutical Calcitonin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Hybio Pharmaceutical Calcitonin Injection Product Portfolio
- 7.8.5 Hybio Pharmaceutical Recent Developments
- 7.9 Guoda Bio
- 7.9.1 Guoda Bio Company Information
- 7.9.2 Guoda Bio Business Overview
- 7.9.3 Guoda Bio Calcitonin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Guoda Bio Calcitonin Injection Product Portfolio
- 7.9.5 Guoda Bio Recent Developments
- 7.10 Future Health Pharma
- 7.10.1 Future Health Pharma Company Information
- 7.10.2 Future Health Pharma Business Overview
- 7.10.3 Future Health Pharma Calcitonin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Future Health Pharma Calcitonin Injection Product Portfolio
- 7.10.5 Future Health Pharma Recent Developments
- 7.11 DAPHAE
- 7.11.1 DAPHAE Company Information
- 7.11.2 DAPHAE Business Overview
- 7.11.3 DAPHAE Calcitonin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 DAPHAE Calcitonin Injection Product Portfolio
- 7.11.5 DAPHAE Recent Developments
- 7.12 CSPC
- 7.12.1 CSPC Company Information
- 7.12.2 CSPC Business Overview
- 7.12.3 CSPC Calcitonin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 CSPC Calcitonin Injection Product Portfolio
- 7.12.5 CSPC Recent Developments
- 7.13 Asahi Kasei Pharma
- 7.13.1 Asahi Kasei Pharma Company Information
- 7.13.2 Asahi Kasei Pharma Business Overview
- 7.13.3 Asahi Kasei Pharma Calcitonin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 Asahi Kasei Pharma Calcitonin Injection Product Portfolio
- 7.13.5 Asahi Kasei Pharma Recent Developments
8 North America
- 8.1 North America Calcitonin Injection Market Size by Type
- 8.1.1 North America Calcitonin Injection Revenue by Type (2021-2032)
- 8.1.2 North America Calcitonin Injection Sales by Type (2021-2032)
- 8.1.3 North America Calcitonin Injection Price by Type (2021-2032)
- 8.2 North America Calcitonin Injection Market Size by Application
- 8.2.1 North America Calcitonin Injection Revenue by Application (2021-2032)
- 8.2.2 North America Calcitonin Injection Sales by Application (2021-2032)
- 8.2.3 North America Calcitonin Injection Price by Application (2021-2032)
- 8.3 North America Calcitonin Injection Market Size by Country
- 8.3.1 North America Calcitonin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Calcitonin Injection Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Calcitonin Injection Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Calcitonin Injection Market Size by Type
- 9.1.1 Europe Calcitonin Injection Revenue by Type (2021-2032)
- 9.1.2 Europe Calcitonin Injection Sales by Type (2021-2032)
- 9.1.3 Europe Calcitonin Injection Price by Type (2021-2032)
- 9.2 Europe Calcitonin Injection Market Size by Application
- 9.2.1 Europe Calcitonin Injection Revenue by Application (2021-2032)
- 9.2.2 Europe Calcitonin Injection Sales by Application (2021-2032)
- 9.2.3 Europe Calcitonin Injection Price by Application (2021-2032)
- 9.3 Europe Calcitonin Injection Market Size by Country
- 9.3.1 Europe Calcitonin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Calcitonin Injection Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Calcitonin Injection Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Calcitonin Injection Market Size by Type
- 10.1.1 China Calcitonin Injection Revenue by Type (2021-2032)
- 10.1.2 China Calcitonin Injection Sales by Type (2021-2032)
- 10.1.3 China Calcitonin Injection Price by Type (2021-2032)
- 10.2 China Calcitonin Injection Market Size by Application
- 10.2.1 China Calcitonin Injection Revenue by Application (2021-2032)
- 10.2.2 China Calcitonin Injection Sales by Application (2021-2032)
- 10.2.3 China Calcitonin Injection Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Calcitonin Injection Market Size by Type
- 11.1.1 Asia Calcitonin Injection Revenue by Type (2021-2032)
- 11.1.2 Asia Calcitonin Injection Sales by Type (2021-2032)
- 11.1.3 Asia Calcitonin Injection Price by Type (2021-2032)
- 11.2 Asia Calcitonin Injection Market Size by Application
- 11.2.1 Asia Calcitonin Injection Revenue by Application (2021-2032)
- 11.2.2 Asia Calcitonin Injection Sales by Application (2021-2032)
- 11.2.3 Asia Calcitonin Injection Price by Application (2021-2032)
- 11.3 Asia Calcitonin Injection Market Size by Country
- 11.3.1 Asia Calcitonin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Calcitonin Injection Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Calcitonin Injection Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Calcitonin Injection Market Size by Type
- 12.1.1 SAMEA Calcitonin Injection Revenue by Type (2021-2032)
- 12.1.2 SAMEA Calcitonin Injection Sales by Type (2021-2032)
- 12.1.3 SAMEA Calcitonin Injection Price by Type (2021-2032)
- 12.2 SAMEA Calcitonin Injection Market Size by Application
- 12.2.1 SAMEA Calcitonin Injection Revenue by Application (2021-2032)
- 12.2.2 SAMEA Calcitonin Injection Sales by Application (2021-2032)
- 12.2.3 SAMEA Calcitonin Injection Price by Application (2021-2032)
- 12.3 SAMEA Calcitonin Injection Market Size by Country
- 12.3.1 SAMEA Calcitonin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Calcitonin Injection Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Calcitonin Injection Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Calcitonin Injection Value Chain Analysis
- 13.1.1 Calcitonin Injection Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Calcitonin Injection Production Mode & Process
- 13.2 Calcitonin Injection Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Calcitonin Injection Distributors
- 13.2.3 Calcitonin Injection Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst